Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Turn Therapeutics Inc Is A Clinical-Stage Biotechnology And Medical Device Development Company Built Around Its Proprietary Platform Technology Called Permafusion Designed To Enhance Drug Performance. The Company Is Developing Non-Systemic, Non-Biologic Topical Immunomodulators For Inflammatory Skin Disease. Its Program, Gx-03, Is Being Studied For Moderate-To-Severe Eczema Based On Preclinical Evidence Of Cytokine Inhibition And Reduced Eczema Severity, As Well As A Favorable Real-World Tolerability Record From Prior Cleared Medical Device Indications For The Same Formula. Gx-03 Is Currently Being Evaluated In An Ongoing, Randomized, Double-Blind, Vehicle-Controlled Clinical Study Designed To Assess Its Potential As A Topical Treatment For Moderate-To-Severe Eczema.